Im­munother­a­py biotech un­stealths with $13M; An­ti-in­fec­tion can­di­date for CF pass­es safe­ty tri­al

Shen­non Biotech­nolo­gies has raised $13 mil­lion in seed fund­ing for a sin­gle cell plat­form to cre­ate more ef­fec­tive im­munother­a­pies. The com­pa­ny says the plat­form can …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.